Resultados: 9

    Guía para el cuidado crítico de pacientes adultos graves con Coronavirus (COVID-19) en las Américas (Versión larga)

    Esta guía de práctica clínica provee recomendaciones informadas en la evidencia para el control de la infección, recolección de muestras, cuidado de soporte, tratamiento farmacológico y prevención de complicaciones. Las recomendaciones están dirigidas a todo el personal de salud que atiende a los...

    Guidelines for Critical Care of Seriously Ill Adult Patients with Coronavirus (COVID-19) in the Americas (Short version)

    This clinical practice guideline provides evidence-informed recommendations for infection control, specimen collection, supportive care, pharmacological treatment, and prevention of complications. The recommendations are directed to all health care staff who deal with patients in emergency departments an...

    Advice on the use of masks in the community, during home care and in health care settings in the context of the novel coronavirus (2019-nCoV) outbreak

    This document provides rapid advice on the use of medical masks in communities, at home and at healthcare facilities in areas that have reported outbreaks caused by the 2019 novel coronavirus (2019-nCoV). It is intended for public health and infection prevention and control (IPC) professionals, healthcar...

    Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected: Interim guidance

    This document is intended for clinicians taking care of hospitalised adult and paediatric patients with severe acute respiratory infection (SARI) when a nCoV infection is suspected. It is not meant to replace clinical judgment or specialist consultation but rather to strengthen clinical management of the...

    Infection prevention and control during health care when novel coronavirus (nCoV) infection is suspected Interim guidance 25 January 2020

    This is the first edition of guidance on infection prevention and control (IPC) strategies for use when infection with a novel coronavirus (2019-nCoV) is suspected. It has been adapted from WHO’s Infection prevention and control during health care for probable or confirmed cases of Middle East respirat...

    Home care for patients with suspected novel coronavirus (2019-nCoV) infection presenting with mild symptoms and management of contacts: Interim guidance

    WHO has developed this interim guidance to meet the need for recommendations on safe home care for patients with suspected COVID-19 who present with mild symptoms a and on public health measures related to the management of their contacts. This document was adapted from the interim guidance on Middle Eas...

    Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases: Interim guidance

    The purpose of this document is to provide interim guidance to laboratories and stakeholders involved in laboratory testing of patients who meet the definition of suspected case of pneumonia associated with a novel coronavirus identified in Wuhan, China....

    Canadian Critical Care Society clinical practice guideline: The use of vasopressin and vasopressin analogues in critically ill adults with distributive shock

    Canadian Journal of Anesthesia; 67 (March), 2020
    Purpose: Hemodynamic management of adults with distributive shock often includes the use of catecholamine-based vasoconstricting medications. It is unclear whether adding vasopressin or vasopressin analogues to catecholamine therapy is beneficial in the management of patients with distributive shock. The...